Trump signs order to speed review of psychedelics, including controversial drug ibogaine

al.com al.com —

President Donald Trump has directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine.

The administration is taking steps to ease restrictions and spur research on using the drugs for medical purposes, including conditions such as severe depression.

Read full article at al.com →

Trump accelerates psychedelic drug research